Stephen Kang, MDThe James Cancer Center
- Skull Base Tumors
- Head and Neck Cancer
- Thyroid Cancer
- Salivary Gland Cancers
- Facial Cancers
- Thyroid Diseases
Make an Appointment
I am an expert head and neck surgeon who specializes in the treatment of benign and malignant head and neck tumors. My areas of special interest are in skin cancers (such as melanomas), salivary gland tumors and tongue cancer. I perform more than 270 major head and neck operations (including reconstructions) every year. In 2017, I was rated in the top 10 percent of physicians in the nation for patient satisfaction.
After graduating from medical school, I completed five years of head and neck surgery residency at the University of Michigan. I then completed an additional year of advanced training (fellowship) at the OSUCCC – James specializing in the management of head and neck cancers.
I train future surgeons and teach medical students in my roles as associate residency program director, director of Medical Student Education and assistant professor in the Department of Otolaryngology - Head & Neck Surgery.
I am very interested in science and research, which directly impact patient care. I study how much tissue needs to be removed for each different type of cancer (known as surgical margin), reconstruction involving tissue transplantation, and genes that predict how skin cancers spread. The OSUCCC – James gives me the resources to be able to further my research in order to help more patients, and I am proud to work here.
Education and Background
University of Michigan Medical School
Ann Arbor, MI
University of Michigan Medical Center
Ann Arbor, MI
Head & Neck Oncology
Ohio State University Wexner Medical Center
- American Board of Otolaryngology
- Department of Otolaryngology
I see patients at
The James Cancer Hospital and Solove Research Institute
460 West 10th Avenue, Columbus, Ohio 43210
Consulting and Related Relationships
At The Ohio State University Wexner Medical Center, we support a faculty member’s research and consulting in collaboration with medical device, research and/or drug companies because a faculty member’s expertise can guide important advancements in the practice of medicine and improve patient care. In order to provide effective management of these relationships, the university requires annual disclosures from all faculty members with external interests related to their university responsibilities. As of 3/28/2017, Dr. Kang has reported financial relationships with the medical device, research and/or drug companies listed below. If you have questions about the relationships listed below, please ask the faculty member. If you have questions about how these relationships are monitored by The Ohio State University Wexner Medical Center, please contact our Compliance Office at 614-293-7802.